ADMA BIOLOGICS, INC. (ADMA) Free cash flow 2016–2025
ADMA BIOLOGICS, INC. (ADMA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$27.8MFY2025 · since FY2016: -$18.3M → $27.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $27.8M | -74.8% |
| FY2024 | $110.4M | +2641.3% |
| FY2023 | $4.0M | +105.5% |
| FY2022 | -$73.4M | +41.7% |
| FY2021 | -$125.9M | -9.7% |
| FY2020 | -$114.7M | -43.4% |
| FY2019 | -$80.0M | -23.5% |
| FY2018 | -$64.8M | -62.1% |
| FY2017 | -$39.9M | -117.8% |
| FY2016 | -$18.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice